Highlights

[PHARMA] YoY Quarter Result on 2012-06-30 [#2]

Stock [PHARMA]: PHARMANIAGA BHD
Announcement Date 08-Aug-2012
Admission Sponsor -
Sponsor -
Financial Year 31-Dec-2012
Quarter 30-Jun-2012  [#2]
Profit Trend QoQ -     -45.22%    YoY -     12.88%
Quarter Report


View:


Show?  YoY % Horiz. %

Quarter Result
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
Revenue 512,845 525,072 437,633 456,737 396,435 350,335 333,212 7.45%
  YoY % -2.33% 19.98% -4.18% 15.21% 13.16% 5.14% -
  Horiz. % 153.91% 157.58% 131.34% 137.07% 118.97% 105.14% 100.00%
PBT 25,056 24,622 9,605 27,618 19,380 20,327 24,337 0.49%
  YoY % 1.76% 156.35% -65.22% 42.51% -4.66% -16.48% -
  Horiz. % 102.95% 101.17% 39.47% 113.48% 79.63% 83.52% 100.00%
Tax -8,414 -8,665 -3,434 -11,541 -5,335 -5,809 -5,814 6.35%
  YoY % 2.90% -152.33% 70.25% -116.33% 8.16% 0.09% -
  Horiz. % 144.72% 149.04% 59.06% 198.50% 91.76% 99.91% 100.00%
NP 16,642 15,957 6,171 16,077 14,045 14,518 18,523 -1.77%
  YoY % 4.29% 158.58% -61.62% 14.47% -3.26% -21.62% -
  Horiz. % 89.85% 86.15% 33.32% 86.79% 75.82% 78.38% 100.00%
NP to SH 16,217 15,975 5,865 15,713 13,920 14,747 17,697 -1.44%
  YoY % 1.51% 172.38% -62.67% 12.88% -5.61% -16.67% -
  Horiz. % 91.64% 90.27% 33.14% 88.79% 78.66% 83.33% 100.00%
Tax Rate 33.58 % 35.19 % 35.75 % 41.79 % 27.53 % 28.58 % 23.89 % 5.84%
  YoY % -4.58% -1.57% -14.45% 51.80% -3.67% 19.63% -
  Horiz. % 140.56% 147.30% 149.64% 174.93% 115.24% 119.63% 100.00%
Total Cost 496,203 509,115 431,462 440,660 382,390 335,817 314,689 7.88%
  YoY % -2.54% 18.00% -2.09% 15.24% 13.87% 6.71% -
  Horiz. % 157.68% 161.78% 137.11% 140.03% 121.51% 106.71% 100.00%
Net Worth 528,477 502,293 480,568 481,394 451,517 417,065 400,161 4.74%
  YoY % 5.21% 4.52% -0.17% 6.62% 8.26% 4.22% -
  Horiz. % 132.07% 125.52% 120.09% 120.30% 112.83% 104.22% 100.00%
Dividend
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
Div 18,134 10,356 8,810 8,827 - 50,261 28,888 -7.46%
  YoY % 75.10% 17.55% -0.19% 0.00% 0.00% 73.98% -
  Horiz. % 62.77% 35.85% 30.50% 30.56% 0.00% 173.98% 100.00%
Div Payout % 111.82 % 64.83 % 150.22 % 56.18 % - % 340.83 % 163.24 % -6.11%
  YoY % 72.48% -56.84% 167.39% 0.00% 0.00% 108.79% -
  Horiz. % 68.50% 39.71% 92.02% 34.42% 0.00% 208.79% 100.00%
Equity
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
Net Worth 528,477 502,293 480,568 481,394 451,517 417,065 400,161 4.74%
  YoY % 5.21% 4.52% -0.17% 6.62% 8.26% 4.22% -
  Horiz. % 132.07% 125.52% 120.09% 120.30% 112.83% 104.22% 100.00%
NOSH 259,057 258,914 258,370 117,700 106,994 106,939 106,995 15.87%
  YoY % 0.06% 0.21% 119.52% 10.01% 0.05% -0.05% -
  Horiz. % 242.12% 241.99% 241.48% 110.01% 100.00% 99.95% 100.00%
Ratio Analysis
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
NP Margin 3.25 % 3.04 % 1.41 % 3.52 % 3.54 % 4.14 % 5.56 % -8.56%
  YoY % 6.91% 115.60% -59.94% -0.56% -14.49% -25.54% -
  Horiz. % 58.45% 54.68% 25.36% 63.31% 63.67% 74.46% 100.00%
ROE 3.07 % 3.18 % 1.22 % 3.26 % 3.08 % 3.54 % 4.42 % -5.89%
  YoY % -3.46% 160.66% -62.58% 5.84% -12.99% -19.91% -
  Horiz. % 69.46% 71.95% 27.60% 73.76% 69.68% 80.09% 100.00%
Per Share
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
RPS 197.97 202.80 169.38 388.05 370.52 327.60 311.43 -7.27%
  YoY % -2.38% 19.73% -56.35% 4.73% 13.10% 5.19% -
  Horiz. % 63.57% 65.12% 54.39% 124.60% 118.97% 105.19% 100.00%
EPS 6.26 6.17 2.27 13.35 13.01 13.79 16.54 -14.94%
  YoY % 1.46% 171.81% -83.00% 2.61% -5.66% -16.63% -
  Horiz. % 37.85% 37.30% 13.72% 80.71% 78.66% 83.37% 100.00%
DPS 7.00 4.00 3.41 7.50 0.00 47.00 27.00 -20.14%
  YoY % 75.00% 17.30% -54.53% 0.00% 0.00% 74.07% -
  Horiz. % 25.93% 14.81% 12.63% 27.78% 0.00% 174.07% 100.00%
NAPS 2.0400 1.9400 1.8600 4.0900 4.2200 3.9000 3.7400 -9.60%
  YoY % 5.15% 4.30% -54.52% -3.08% 8.21% 4.28% -
  Horiz. % 54.55% 51.87% 49.73% 109.36% 112.83% 104.28% 100.00%
Adjusted Per Share Value based on latest NOSH - 261,705
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
RPS 195.96 200.63 167.22 174.52 151.48 133.87 127.32 7.45%
  YoY % -2.33% 19.98% -4.18% 15.21% 13.15% 5.14% -
  Horiz. % 153.91% 157.58% 131.34% 137.07% 118.98% 105.14% 100.00%
EPS 6.20 6.10 2.24 6.00 5.32 5.63 6.76 -1.43%
  YoY % 1.64% 172.32% -62.67% 12.78% -5.51% -16.72% -
  Horiz. % 91.72% 90.24% 33.14% 88.76% 78.70% 83.28% 100.00%
DPS 6.93 3.96 3.37 3.37 0.00 19.21 11.04 -7.46%
  YoY % 75.00% 17.51% 0.00% 0.00% 0.00% 74.00% -
  Horiz. % 62.77% 35.87% 30.53% 30.53% 0.00% 174.00% 100.00%
NAPS 2.0194 1.9193 1.8363 1.8394 1.7253 1.5936 1.5291 4.74%
  YoY % 5.22% 4.52% -0.17% 6.61% 8.26% 4.22% -
  Horiz. % 132.06% 125.52% 120.09% 120.29% 112.83% 104.22% 100.00%
Price Multiplier on Financial Quarter End Date
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
Date 30/06/15 30/06/14 28/06/13 29/06/12 30/06/11 30/06/10 30/06/09 -
Price 7.1300 4.6100 4.4900 10.1800 5.9000 4.9800 3.8000 -
P/RPS 3.60 2.27 2.65 2.62 1.59 1.52 1.22 19.75%
  YoY % 58.59% -14.34% 1.15% 64.78% 4.61% 24.59% -
  Horiz. % 295.08% 186.07% 217.21% 214.75% 130.33% 124.59% 100.00%
P/EPS 113.90 74.72 197.80 76.25 45.35 36.11 22.97 30.57%
  YoY % 52.44% -62.22% 159.41% 68.14% 25.59% 57.21% -
  Horiz. % 495.86% 325.29% 861.12% 331.95% 197.43% 157.21% 100.00%
EY 0.88 1.34 0.51 1.31 2.21 2.77 4.35 -23.37%
  YoY % -34.33% 162.75% -61.07% -40.72% -20.22% -36.32% -
  Horiz. % 20.23% 30.80% 11.72% 30.11% 50.80% 63.68% 100.00%
DY 0.98 0.87 0.76 0.74 0.00 9.44 7.11 -28.12%
  YoY % 12.64% 14.47% 2.70% 0.00% 0.00% 32.77% -
  Horiz. % 13.78% 12.24% 10.69% 10.41% 0.00% 132.77% 100.00%
P/NAPS 3.50 2.38 2.41 2.49 1.40 1.28 1.02 22.80%
  YoY % 47.06% -1.24% -3.21% 77.86% 9.38% 25.49% -
  Horiz. % 343.14% 233.33% 236.27% 244.12% 137.25% 125.49% 100.00%
Price Multiplier on Announcement Date
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
Date 17/08/15 21/08/14 16/08/13 08/08/12 10/08/11 11/08/10 21/08/09 -
Price 5.6500 4.6200 4.6600 8.8300 5.9000 4.9500 4.0000 -
P/RPS 2.85 2.28 2.75 2.28 1.59 1.51 1.28 14.26%
  YoY % 25.00% -17.09% 20.61% 43.40% 5.30% 17.97% -
  Horiz. % 222.66% 178.12% 214.84% 178.12% 124.22% 117.97% 100.00%
P/EPS 90.26 74.88 205.29 66.14 45.35 35.90 24.18 24.54%
  YoY % 20.54% -63.52% 210.39% 45.84% 26.32% 48.47% -
  Horiz. % 373.28% 309.68% 849.01% 273.53% 187.55% 148.47% 100.00%
EY 1.11 1.34 0.49 1.51 2.21 2.79 4.14 -19.69%
  YoY % -17.16% 173.47% -67.55% -31.67% -20.79% -32.61% -
  Horiz. % 26.81% 32.37% 11.84% 36.47% 53.38% 67.39% 100.00%
DY 1.24 0.87 0.73 0.85 0.00 9.49 6.75 -24.59%
  YoY % 42.53% 19.18% -14.12% 0.00% 0.00% 40.59% -
  Horiz. % 18.37% 12.89% 10.81% 12.59% 0.00% 140.59% 100.00%
P/NAPS 2.77 2.38 2.51 2.16 1.40 1.27 1.07 17.17%
  YoY % 16.39% -5.18% 16.20% 54.29% 10.24% 18.69% -
  Horiz. % 258.88% 222.43% 234.58% 201.87% 130.84% 118.69% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
Earn MQ Points while trading with MQ Traders Group
MQ Affiliate
Earn side income from MQ Affiliate Program
 
 

574  435  584  558 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 PA 0.20+0.015 
 IRIS 0.395+0.025 
 PA-WB 0.14+0.03 
 AT 0.170.00 
 VIVOCOM 0.965+0.13 
 DNEX 0.285+0.005 
 JAKS 0.69+0.015 
 SCIB 2.99+0.45 
 KSTAR 0.115-0.03 
 DNEX-WD 0.055-0.005 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!
PARTNERS & BROKERS